BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III United Kingdom Satellite
Phase of Trial: Phase IV
Latest Information Update: 05 Sep 2019
Price : $35 *
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Sponsors BIOTRONIK
- 28 Sep 2017 Planned End Date changed from 1 Nov 2016 to 1 Dec 2018.
- 28 Sep 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2018.
- 29 Aug 2016 Status changed from not yet recruiting to recruiting.